Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urogynecology Journal
Published in: International Urogynecology Journal 8/2018

01-08-2018 | Editorial

Quo vadis, vaginal mesh in pelvic organ prolapse?

Authors: Stephen Jeffery, Jan-Paul Roovers

Published in: International Urogynecology Journal | Issue 8/2018

Login to get access

Excerpt

The use of vaginal mesh in pelvic organ prolapse (POP) has prompted a new and unprecedented media frenzy. For example, in a highly polarising statement, an Oxford-based professor of evidence-based medicine in a Guardian article recently compared vaginal mesh to the devastation wreaked by thalidomide. We believe that it is now time for a less emotional and more scientific-based voice to be heard on this issue. …
Literature
1.
Altman D, Väyrynen T, Engh ME, Axelsen S, Falconer C, Nordic Transvaginal Mesh Group. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364(19):1826–36.CrossRefPubMed
2.
Glazener CM, Breeman S, Elders A, Hemming C, Cooper KG, Freeman RM, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet. 2017;389(10067):381–92.CrossRefPubMed
3.
Chapple CR, Cruz F, Deffieux X, Milani AL, Arlandis S, Artibani W, et al. Consensus statement of the European Urology Association and the European Urogynaecological Association on the use of implanted materials for treating pelvic organ prolapse and stress urinary incontinence. Eur Urol. 2017;72(3):424–31.CrossRefPubMed
Metadata
Title
Quo vadis, vaginal mesh in pelvic organ prolapse?
Authors
Stephen Jeffery
Jan-Paul Roovers
Publication date
01-08-2018
Publisher
Springer London
Published in
International Urogynecology Journal / Issue 8/2018
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3659-6

Other articles of this Issue 8/2018

International Urogynecology Journal 8/2018 Go to the issue

IUJ Video

Entry into the anterior cul-de-sac during vaginal hysterectomy

Original Article

Manchester–Fothergill procedure versus vaginal hysterectomy with uterosacral ligament suspension: an activity-based costing analysis

Commentary

Commentary on: A cost-effectiveness analysis of onabotulinumtoxin A as first-line treatment for overactive bladder

Original Article

Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse

Original Article

Vaginal hysterectomy with apical fixation and anterior vaginal wall repair for prolapse: surgical technique and medium-term results

Original Article

Modified laparoscopic pectopexy: short-term follow-up and its effects on sexual function and quality of life